Page last updated: 2024-10-17

trimethylenediamine and Glioma

trimethylenediamine has been researched along with Glioma in 1 studies

trimethylenediamine: RN given refers to parent cpd; structure
trimethylenediamine : An alkane-alpha,omega-diamine comprising a propane skeleton with amino substituents at positions 1 and 3.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chapman, SK1
Glant, SK1

Other Studies

1 other study available for trimethylenediamine and Glioma

ArticleYear
Antiproliferative effects of inhibitors of polyamine synthesis in tumors of neural origin.
    Journal of pharmaceutical sciences, 1980, Volume: 69, Issue:6

    Topics: Animals; Antineoplastic Agents; Cadaverine; Cell Division; Cell Line; Diamines; Glioma; Mice; Neopla

1980